RiMO-301

· Coordination Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RiMO-301, covering 2025-09-15 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer [Phase 1, Phase 2]